Protection of renal tubular cells by antioxidants: current knowledge and new trends

Azar Baradaran1, Hamid Nasri2, Mahmoud Rafieian-Kopaei3

  • 1Department of Pathology, Isfahan University of Medical Sciences, Isfahan, Iran.

Cell Journal
|February 17, 2015
PubMed

Insights

Oxidative stress contributes to acute kidney injury. While antioxidants show promise in lab studies, long-term clinical trials, especially with single antioxidants like vitamin C, yield inconsistent results, prompting further investigation into their efficacy.

Area of Science:

  • Nephrology
  • Toxicology
  • Biochemistry

Background:

  • Acute kidney injury (AKI) often results from toxic or ischemic insults, with oxidative stress implicated as a major factor.
  • Reduced renal tubular cell regeneration during injury is a growing area of research in AKI.
  • Antioxidants are being investigated for their potential in preventing and treating oxidative stress-related conditions, including kidney damage.

Purpose of the Study:

  • To explore the reasons behind the inconsistent outcomes of long-term clinical trials on antioxidant use for preventing and treating kidney injuries.
  • To discuss the potential explanations for the discrepancy between laboratory findings and clinical trial results regarding antioxidant efficacy in AKI.

Main Methods:

  • Literature review and analysis of existing research on oxidative stress in acute kidney injury.
  • Examination of data from laboratory trials and long-term clinical studies involving antioxidants.
  • Discussion of the role of single antioxidant supplementation versus broader antioxidant strategies.

Main Results:

  • Laboratory studies frequently demonstrate the protective effects of antioxidants against kidney injury induced by free radicals.
  • Long-term clinical trials, particularly those examining single antioxidant supplements like vitamin C, have not consistently confirmed these benefits.
  • The efficacy of antioxidants in clinical settings may be influenced by factors not fully replicated in preclinical models.

Conclusions:

  • The effectiveness of antioxidants in treating AKI in humans requires further investigation, considering the complexities of oxidative stress and cellular regeneration.
  • Discrepancies between preclinical and clinical findings highlight the need for more robust, long-term studies and potentially combination therapies.
  • Understanding the limitations of single antioxidant interventions is crucial for developing effective strategies against kidney damage.

Related Concept Videos

Drug Elimination by Renal Route: Tubular Secretion01:15

Drug Elimination by Renal Route: Tubular Secretion

Once the process of glomerular filtration is completed, blood carrying unfiltered drug molecules traverses through efferent arterioles and makes its way into the peritubular capillaries in the proximal tubule. A variety of carriers play a pivotal role in actively secreting drugs from these peritubular capillaries into the tubular fluid. The organic anion transporter transfers acidic drugs, against an electrochemical gradient, from the peritubular capillaries into the renal tubule cells and...
3.8K
Renal Drug Excretion: Tubular Secretion01:28

Renal Drug Excretion: Tubular Secretion

Active tubular secretion is a robust, energy-demanding process that utilizes carrier systems to transport drugs into renal tubules. The active renal secretion systems include the organic anion transporter (OAT) for weak acids and the organic cation transporter (OCT) for weak bases. Structurally similar drugs can compete for the same transporter, potentially leading to drug accumulation and toxicity. However, this principle can be exploited therapeutically. One example is probenecid (Probalan),...
1.2K
Drug Elimination by Renal Route: Tubular Reabsorption01:22

Drug Elimination by Renal Route: Tubular Reabsorption

During the process of renal excretion, as the glomerular filtrate progresses to the distal convoluted tubule (DCT), drugs that are highly permeable, lipophilic, and nonionized undergo passive reabsorption from the tubular fluid into the surrounding peritubular capillaries. This reabsorption process restricts their elimination through the kidneys. However, the majority of drugs are either weak acids or weak bases, and their ionization level is dependent on pH. By altering the pH of urine, the...
5.7K
Renal Drug Excretion: Tubular Reabsorption01:25

Renal Drug Excretion: Tubular Reabsorption

Tubular reabsorption, a process occurring post-glomerular filtration of drugs in the renal tubule, is a critical determinant of drug half-life. During the process of renal excretion, as the glomerular filtrate progresses to the distal convoluted tubule (DCT), drugs that are highly permeable, lipophilic, and nonionized undergo passive reabsorption from the tubular fluid into the surrounding peritubular capillaries. This reabsorption process restricts their elimination through the kidneys. This...
1.2K
Tubular Reabsorption and Secretion01:28

Tubular Reabsorption and Secretion

Tubular secretion and reabsorption are two critical processes in the nephron tubule of the kidneys. When the fluid filtered from the glomerulus enters the proximal convoluted tubule, it is referred to as filtrate, and its composition changes due to tubular reabsorption and secretion.
Tubular reabsorption is a selective process that starts when the filtrate enters the proximal tubules. It involves substances traveling through the transcellular route (through the tubule cell and peritubular...
9.0K
Physiology of the Genitourinary System II: Tubular Reabsorption and Secretion01:22

Physiology of the Genitourinary System II: Tubular Reabsorption and Secretion

The kidneys maintain homeostasis through filtration, reabsorption, and secretion. Tubular reabsorption and secretion are crucial in forming urine and regulating electrolytes, water balance, and waste elimination.Tubular Reabsorption and Secretion ProcessesTubular reabsorption is the process that reclaims essential substances such as electrolytes, glucose, amino acids, and water from the glomerular filtrate back into the bloodstream. This is achieved through passive and active transport...
2.2K